Sanofi-Synthelabo
Records under this name other than patents Sanofi-Synthelabo holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,524,857 | Pharmaceutical Combinations Based on Pyridoindolone Derivatives and Anticancer Agents Formerly held Term ended Ended no later than Oct 26, 2024 · Medium confidence | Term ended | Ended no later than Oct 26, 2024 | Medium confidence |
| US 7,462,725 | Chloromethylation of Thiophene Formerly held Term ended Term ended Sep 29, 2024 · High confidence | Term ended | Term ended Sep 29, 2024 | High confidence |
| US 7,235,554 | 3-Heteroarly-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b] INDOLE-1-Acetamide Derivatives, Preparation and Use Thereof in Medicaments Formerly held Term ended Term ended Feb 24, 2024 · High confidence | Term ended | Term ended Feb 24, 2024 | High confidence |
| US 7,288,659 | Acylaminothiazole Derivatives, Their Preparation and Therapeutic Use Formerly held Term ended Term ended Jan 29, 2024 · High confidence | Term ended | Term ended Jan 29, 2024 | High confidence |
| US 7,223,750 | Derivatives of 5-(PYRIDIN-3-YL)-1-Azabicyclo[3.2.1] Octane, the Preparation Thereof and the Application of Same in Therapeutics Formerly held Term ended Term ended Jul 10, 2023 · High confidence | Term ended | Term ended Jul 10, 2023 | High confidence |
| US 7,381,835 | Resolution Process for (R)-(-)-2-Hydroxy-2-(2-Chlorophenyl) Acetic Acid Formerly held Term ended Term ended Jun 9, 2023 · High confidence | Term ended | Term ended Jun 9, 2023 | High confidence |
| US 7,157,454 | Derivatives of N-(ARYLSULFONYL)beta-Aminoacids Comprising a Substituted Aminomethyl Group, the Preparation Method Thereof and the Pharmaceutical Compositions Containing Same Formerly held Term ended Term ended Apr 20, 2023 · High confidence | Term ended | Term ended Apr 20, 2023 | High confidence |
| US 7,928,073 | Purified Polypeptides Having IL-13 Receptor Activity Formerly held Lapsed on the fee record Ended Apr 19, 2023 · High confidence | Lapsed on the fee record | Ended Apr 19, 2023 | High confidence |
| US 7,109,194 | 3-Heteroaryl-3, 5-Dihydro-4-OXO-4H-PYRIDAZINO[4, 5-B]INDOLE-1-Carboxamide Derivatives Their Preparations and Therapeutic Use Formerly held Term ended Term ended Mar 15, 2023 · High confidence | Term ended | Term ended Mar 15, 2023 | High confidence |
| US 7,094,223 | Device for Protecting a Syringe Needle Formerly held Term ended Term ended Dec 24, 2022 · High confidence | Term ended | Term ended Dec 24, 2022 | High confidence |